Nuvalent (NASDAQ:NUVL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Nuvalent (NUVL) operate in?

Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Nuvalent Stock (NASDAQ: NUVL) stock price, news, charts, stock research, profile.

Open	$73.92
Close	-
Volume / Avg.	26.09K / 463.75K
Day Range	72.64 - 74.60
52 Wk Range	38.78 - 89.39
Market Cap	$4.76B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	35.3%
Days to Cover	15.91

Recent News

Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts.

Lekha Gupta

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance to uncover new information.

Chris Katje

Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold

Stifel initiated coverage on Nuvalent Inc (NASDAQ: NUVL), recognizing that adopting a bullish stance in anticipation of Phase 1 cancer drug data, mainly when derived from heavily pretreated patients, has proven unprofitable for approximately two years.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Nuvalent Inc

Sector

Health Care

Industry

Biotechnology

Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nuvalent (NUVL) stock?

You can purchase shares of Nuvalent (NASDAQ:NUVL) through any online brokerage.

View our list of the best stock brokerages

Who are Nuvalent (NUVL) competitors?

Other companies in Nuvalent’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

What is the target price for Nuvalent (NUVL) stock?

There is no analysis for Nuvalent.

What is the forecast for Nuvalent (NUVL) stock?

Nuvalent has a consensus price target of $70.67.

Current stock price for Nuvalent (NUVL)?

The stock price for Nuvalent (NASDAQ: NUVL) is $73.74 last updated Today at July 8, 2024 at 10:09 AM EDT.

Does Nuvalent (NUVL) pay a dividend?

There are no upcoming dividends for Nuvalent.

When is Nuvalent (NASDAQ:NUVL) reporting earnings?

Nuvalent’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Nuvalent (NUVL) going to split?

There is no upcoming split for Nuvalent.

What sector and industry does Nuvalent (NUVL) operate in?

Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Nuvalent

Nuvalent (NUVL) Forecast